# Heron Therapeutics, Inc.: filings

HRTX · Nasdaq · CIK 818033 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hrtx.md) · [Financials](/companies/hrtx/financials.md) · [Filings](/companies/hrtx/filings.md) · [Insiders](/companies/hrtx/insiders.md)

## Reports and events: 405 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 375, 8-K 279, SC 13G/A 80, 10-Q 53, 3 38, SC 13G 32, SC 13D/A 21, DEF 14A 20, 10-K 18, 424B5 17, S-8 17, 424B3 16, EFFECT 14, UPLOAD 13, PRE 14A 10, S-3 10, 4/A 9, CORRESP 9, 5 8, DEFA14A 8, D 5, ARS 4, CT ORDER 4, SCHEDULE 13G/A 4, 10-K/A 3, 3/A 3, 8-K/A 3, S-3ASR 3, 424B2 2, 8-A12B/A 2, POS AM 2, S-1 2, S-1/A 2, SC 13D 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, 25-NSE 1, 8-A12B 1, CERTNAS 1, FWP 1, PRER14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 17:00 ET | [8-K](/filings/0001193125-26-407728.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-407728 |
| 2026-08-14 | 16:30 ET | [8-K](/filings/0001193125-26-352403.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-26-352403 |
| 2026-08-10 | 08:00 ET | [10-Q](/filings/0001193125-26-341301.md) | Quarterly report, period 2026-06-30 | 0001193125-26-341301 |
| 2026-08-10 | 08:00 ET | [8-K](/filings/0001193125-26-341300.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-341300 |
| 2026-06-25 | 17:00 ET | [8-K](/filings/0001193125-26-282988.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-282988 |
| 2026-06-16 | 14:49 ET | [8-K](/filings/0001193125-26-272388.md) | 5.07 Shareholder vote results | 0001193125-26-272388 |
| 2026-06-02 | 17:15 ET | [8-K](/filings/0001193125-26-253851.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-253851 |
| 2026-05-11 | 08:00 ET | [10-Q](/filings/0001193125-26-215755.md) | Quarterly report, period 2026-03-31 | 0001193125-26-215755 |
| 2026-05-11 | 08:00 ET | [8-K](/filings/0001193125-26-215752.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-215752 |
| 2026-04-30 | 14:09 ET | [DEF 14A](/filings/0001193125-26-196306.md) | Proxy statement, period 2026-04-30 | 0001193125-26-196306 |
| 2026-04-06 | 08:30 ET | [8-K](/filings/0001193125-26-142947.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-142947 |
| 2026-02-26 | 08:06 ET | [10-K](/filings/0001193125-26-073515.md) | Annual report, period 2025-12-31 | 0001193125-26-073515 |
| 2026-02-26 | 08:00 ET | [8-K](/filings/0001193125-26-073502.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073502 |
| 2026-01-09 | 13:08 ET | [8-K](/filings/0001193125-26-008631.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-008631 |
| 2025-11-04 | 08:00 ET | [10-Q](/filings/0001193125-25-263618.md) | Quarterly report, period 2025-09-30 | 0001193125-25-263618 |
| 2025-11-04 | 08:00 ET | [8-K](/filings/0001193125-25-263617.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263617 |
| 2025-10-29 | 16:05 ET | [8-K](/filings/0001193125-25-256300.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-256300 |
| 2025-10-17 | 18:02 ET | [SCHEDULE 13D/A](/filings/0000902664-25-004460.md) | Ownership report, active investor, amended | 0000902664-25-004460 |
| 2025-10-15 | 16:09 ET | [8-K](/filings/0001193125-25-240253.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-240253 |
| 2025-09-19 | 16:05 ET | [DEF 14A](/filings/0001193125-25-209064.md) | Proxy statement, period 2025-10-13 | 0001193125-25-209064 |
| 2025-08-28 | 17:02 ET | [8-K](/filings/0000950170-25-112048.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-112048 |
| 2025-08-15 | 07:45 ET | [8-K](/filings/0000950170-25-109234.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-109234 |
| 2025-08-12 | 18:00 ET | [SCHEDULE 13D/A](/filings/0000902664-25-003536.md) | Ownership report, active investor, amended | 0000902664-25-003536 |
| 2025-08-12 | 16:45 ET | [8-K](/filings/0000950170-25-107416.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-107416 |
| 2025-08-12 | 16:35 ET | [8-K](/filings/0000950170-25-107404.md) | 1.01 Entry into a material agreement | 0000950170-25-107404 |
| 2025-08-08 | 07:45 ET | [10-Q](/filings/0000950170-25-105475.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105475 |
| 2025-08-08 | 07:45 ET | [8-K](/filings/0000950170-25-105474.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-105474 |
| 2025-06-18 | 18:17 ET | [8-K](/filings/0000950170-25-087555.md) | 5.07 Shareholder vote results | 0000950170-25-087555 |
| 2025-05-06 | 07:45 ET | [10-Q](/filings/0000950170-25-063971.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063971 |
| 2025-05-06 | 07:45 ET | [8-K](/filings/0000950170-25-063973.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063973 |
| 2025-05-06 | 07:30 ET | [8-K](/filings/0000950170-25-063967.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-063967 |
| 2025-04-30 | 13:52 ET | [DEF 14A](/filings/0000950170-25-060882.md) | Proxy statement, period 2025-06-12 | 0000950170-25-060882 |
| 2025-04-29 | 18:56 ET | [8-K](/filings/0000950170-25-059479.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-059479 |
| 2025-02-27 | 07:45 ET | [10-K](/filings/0000950170-25-028374.md) | Annual report, period 2024-12-31 | 0000950170-25-028374 |
| 2025-02-27 | 07:45 ET | [8-K](/filings/0000950170-25-028372.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028372 |
| 2025-02-20 | 13:51 ET | [8-K](/filings/0000950170-25-023958.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-023958 |
| 2024-12-23 | 16:05 ET | [8-K](/filings/0000950170-24-139569.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-139569 |
| 2024-12-03 | 17:15 ET | [8-K](/filings/0000950170-24-132874.md) | 8.01 Other events | 0000950170-24-132874 |
| 2024-11-12 | 08:56 ET | [10-Q](/filings/0000950170-24-124698.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124698 |
| 2024-11-12 | 08:06 ET | [8-K](/filings/0000950170-24-124626.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124626 |
| 2024-11-04 | 17:09 ET | [8-K](/filings/0000950170-24-120902.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0000950170-24-120902 |
| 2024-08-06 | 16:05 ET | [10-Q](/filings/0000950170-24-091764.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091764 |
| 2024-08-06 | 16:05 ET | [8-K](/filings/0000950170-24-091769.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091769 |
| 2024-07-02 | 08:44 ET | [8-K](/filings/0000950170-24-080026.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-080026 |
| 2024-06-18 | 16:43 ET | [8-K](/filings/0000950170-24-074952.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-074952 |
| 2024-05-31 | 11:08 ET | [SC 13D/A](/filings/0000921895-24-001343.md) | Ownership report, active investor, amended | 0000921895-24-001343 |
| 2024-05-29 | 08:05 ET | [8-K](/filings/0000950170-24-065636.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-065636 |
| 2024-05-07 | 08:05 ET | [10-Q](/filings/0000950170-24-053964.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053964 |
| 2024-05-07 | 08:05 ET | [8-K](/filings/0000950170-24-053963.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053963 |
| 2024-04-29 | 14:33 ET | [DEF 14A](/filings/0001140361-24-022881.md) | Proxy statement, period 2024-06-13 | 0001140361-24-022881 |

Page 1 of 9. [Older](/companies/hrtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:10 ET. No prices; not investment advice.